CURRIE, MARK G.,MAHAJAN-MIKLOS, SHALINA,NORMAN, THEA,MILNE, G. TODD
申请号：
CA2514507
公开号：
CA2514507C
申请日:
2004.01.28
申请国别(地区):
CA
年份:
2012
代理人:
摘要：
The present invention features compositions and related methods for treatingIBS and other gastrointestinal disorders and conditions (e.g.,gastrointestinal motility disorders, functional gastrointestinal disorders,gastroesophageal reflux disease (GERD), Crohn's disease, ulcerative colitis,Inflammatory bowel disease, functional heartburn, dyspepsia (includingfunctional dyspepsia or nonulcer dyspepsia), gastroparesis, chronic intestinalpseudo-obstruction (or colonic pseudo-obstruction), and disorders andconditions associated with constipation, e.g., constipation associated withuse of opiate pain killers, post-surgical constipation, and constipationassociated with neuropathic disorders as well as other conditions anddisorders using peptides and other agents that activate the guanylate cyclaseC (GC-C) receptor.
